Pharmacologics/dietary supplements targeting pain mechanisms tested in mice and/or patients with sickle cell disease
Generic name . | Mechanistic target . | Action . | Sickle subjects . | |
---|---|---|---|---|
Mice . | Humans . | |||
A-425619 | TRPV1 | Antagonist | X | |
AT-200 | NOP/R and MOR | Agonist | X | |
Bosentan | ET-A and ET-B receptors | Antagonist | X | X |
Coenzyme Q10 | Oxidative stress | Inhibitor | X | X |
CP55940 | CB1R and CB2R | Agonist | X | |
Crizanlizumab | P-selectin | Antibody | X | |
Cromolyn | Mast cell | Stabilizer | X | X |
Curcumin | ROS | Inhibitor | X | X |
Duloxetine | Serotonin and norepinephrine reuptake transporter | Inhibitor | X | X |
HC-030031 | TRPA1 | Antagonist | X | |
Imatinib | Mast cell/c-kit/RTK | Inhibitor | X | X |
KN-93 | CaMKII | Inhibitor | X | |
l-arginine | NOS | Substrate | X | |
l-glutamine | Oxidative stress | Antioxidant | X | |
Lovastatin | HMG-CoA reductase | Inhibitor | X | |
PEG-ADA | Adenosine | Inhibitor | X | |
Rapamycin | mTOR | Inhibitor | X | |
HbF | Inducer | |||
Simvastatin | HMG-CoA reductase, calpain-1 | Inhibitor | X | X |
Sivelestat | Neutrophil elastase | Inhibitor | X | |
TAK-242 | TLR4 | Inhibitor | X | |
Trifluoperazine | CaMKIIα | Inhibitor | X | X |
ω-3 fatty acid | Oxidative stress | Antioxidant | X | X |
Generic name . | Mechanistic target . | Action . | Sickle subjects . | |
---|---|---|---|---|
Mice . | Humans . | |||
A-425619 | TRPV1 | Antagonist | X | |
AT-200 | NOP/R and MOR | Agonist | X | |
Bosentan | ET-A and ET-B receptors | Antagonist | X | X |
Coenzyme Q10 | Oxidative stress | Inhibitor | X | X |
CP55940 | CB1R and CB2R | Agonist | X | |
Crizanlizumab | P-selectin | Antibody | X | |
Cromolyn | Mast cell | Stabilizer | X | X |
Curcumin | ROS | Inhibitor | X | X |
Duloxetine | Serotonin and norepinephrine reuptake transporter | Inhibitor | X | X |
HC-030031 | TRPA1 | Antagonist | X | |
Imatinib | Mast cell/c-kit/RTK | Inhibitor | X | X |
KN-93 | CaMKII | Inhibitor | X | |
l-arginine | NOS | Substrate | X | |
l-glutamine | Oxidative stress | Antioxidant | X | |
Lovastatin | HMG-CoA reductase | Inhibitor | X | |
PEG-ADA | Adenosine | Inhibitor | X | |
Rapamycin | mTOR | Inhibitor | X | |
HbF | Inducer | |||
Simvastatin | HMG-CoA reductase, calpain-1 | Inhibitor | X | X |
Sivelestat | Neutrophil elastase | Inhibitor | X | |
TAK-242 | TLR4 | Inhibitor | X | |
Trifluoperazine | CaMKIIα | Inhibitor | X | X |
ω-3 fatty acid | Oxidative stress | Antioxidant | X | X |
ETA and ETB, endothelin A and endothelin B; CB1R/CB2R, cannabinoid receptor 1/2; HMG-CoA reductase, 3-hydroxy-3-methyl-glutaryl–coenzyme reductase; NE, norepinephrine; NOS, nitric oxide synthase; PEG-ADA, polyethylene glycol–modified adenosine deaminase; TRPA1, transient receptor potential cation channel subfamily A, member 1.